Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model

Viral Immunology

Volumn 19, Issue 2, 2006, Pages 202-209

  Liu, Ye ^a,b   Hu, Rongliang ^a   Zhang, Shoufeng ^a   Zhang, Fei ^a   Li, Zhong ^a   Wei, Xuefeng ^c   Chen, Liulian ^c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c Jinyu Group   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; DNA FRAGMENT; ENHANCED GREEN FLUORESCENT PROTEIN; FOOT AND MOUTH DISEASE VACCINE; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; MESSENGER RNA; PROTEIN VP1; RECOMBINANT DNA; RESTRICTION ENDONUCLEASE;

ADENOVIRUS 2; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYADENYLATION; PROPHYLAXIS; PROTEIN EXPRESSION; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SIMIAN VIRUS 40; SWINE; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING;

ADENOVIRUSES, CANINE; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; DISEASE MODELS, ANIMAL; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; RECOMBINATION, GENETIC; SWINE; VACCINATION; VIRAL VACCINES; VIRUS REPLICATION;

CANINE ADENOVIRUS; CANINE ADENOVIRUS TYPE 2; CHICKEN ANEMIA VIRUS; FOOT-AND-MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE VIRUS - TYPE O; SUIDAE;

EID: 33745892629     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.202     Document Type: Article

References (30)

1. Donaldson, A.L., R.P. Kitching, P.V. Barnett. 1996. In: OIE Manual of Standards for Diagnostic Tests and Vaccines. 3rd ed. OIE, Paris, pp. 47-56.
2. Mason, P.W., M.J., Grubman. 2001. Controlling foot-and-mouth disease with vaccine. Aust. Vet. J. 79:342-343.
3. Benvenisti, L., A. Rogel, L. Kuznetzova, S. Bujanover, Y. Becker, Y. Stram. 2001. Gene gun-mediate DNA vaccination against foot-and-mouth disease virus. Vaccine 19:3885-3895.
4. Carrillo, C., A. Wigdorovitz, J.C. Oliveros, P.I. Zamorano, A.M. Sadir, N. Gomez, J. Salinas, J.M. Escribano, M.V. Borca. 1998. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 72:1688-1690.
5. Zamorano, P., A. Wigdorovitz, M. Perez-Filgueira, C. Carrillo, J.M. Escribano, A.M. Sadir, M.V. Borca. 1995. A 10-amino-acid linear sequence of VP1 of foot-and-mouth disease virus containing B-and T-cell epitopes induces protection in mice. Virology 212:614-621.
6. Wang, C.Y., T.Y. Chang, A.M. Walfield, J. Ye, M. Shen, S.P. Chen, M.C. Li, Y.L. Lin, M.H. Jong, P.C. Yang, N. Chyr, E. Kramer, F. Brown. 2002. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 3175:1-8.
7. F., Brown, N. Benkirane, D. Limal, H. Halimi, J.F. Newman, M.H. Van Regenmortel, J.P. Briand, S. Muller. 1999. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Vaccine 18:50-56.
8. Taboga, O., C. Tami, E. Carrillo, J.I. Nunez, A. Rodriguez, J.C. Saiz, E. Blanco, M.L. Valero, X. Roig, J.A. Camarero, D. Andreu, M.G. Mateu, E. Giralt, E. Domingo, F. Sobrino, E.L. Palma. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606-2614.
9. Sanz-Parra, A., M.A. Jimenez-Clavero, M.M. Garcia-Briones, E. Blanco, F. Sobrino, V. Ley. 1999. Recombinant viruses expressing the foot-and- mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virol. 259:129-163.
10. Sumner, J.W., J.H. Shaddock, G. Wu, G.M. Baer. 1988. Oral administration of an attenuated strain of canine adenovirus (type-2) to raccoons, foxes, skunks, and mongoose. Am. J. Vet. Res. 49:169-171.
11. Baer, G.M., R.C. Brooks, C.M. Foggin. 1989. Oral vaccine of dogs fed canine adenovirus in baits. Am. J. Vet. Res. 50:836-837.
12. Xia, X.Z., Q.S. Fan, G.X. Hu. 2000. Isolation and identification of a canine adenovirus avirulent strain. Chin. J. Vet. Drug. 34:1-4.
13. Kremer, E.J., S. Boutin, M. Chillon, Danos O. 2000. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J. Virol. 74:505-512.
14. Fisher, K.J., H. Choi, J. Burda, S.J. Chen, J.M. Wilson. 1996. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217(1):11-22.
15. Reid, S.M., N.P. Ferris, G.H. Hutchings, K. De Clercq. 2001. Diagnosis of foot-and -mouth disease by RT-PCR: evaluation of primers for serotypic characterization of viral RNA in clinical samples. Arch. Virol. 146:113-123.
16. Zhang, S.F., R.L. Hu, J.Q. Niu, X.Z. Xia. 2002. Cloning and identification of the full length infectious genome of canine adenovirus type-2. Chin. J. Vet. Sci. 22:533-535.
17. Shinagawa, M., A. Matsuda, T. Ishiyama. 1983. A rapid and simple method for preparation of adenovirus DNA from infected cells. Microbiol. Immunol. 27:817-822.
18. Schmidt, N.J., E.H. Lennette, C.J. King. 1966. Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections. J. Immunol. 97:64-74.
19. Sambrook, J., E. F. Fritsch, T. Maniatis. (Eds.) 1989. Molecular Cloning: A Laboratory Manual, second ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Rweyemamu, M.M., J.C. Booth, M. Head, T.W. Pay. 1978. Microneutralization test for serological typing and sub-typing of foot-and-mouth disease virus strains. Arch. Virol. 81:107-130.
21. Wu, Q., M.P. Moraes, M.J. Grubman. 2003. Recombinant adenovirus co-expressing capsid protein of two serotypes of foot-and-mouth disease virus: in vitro characterization and induction of neutralizing antibodies against FMDV in swine. Virus Res. 93:211-219.
22. Berinstein, A., Tami, C., Taboga, O., Smitsaart, E., Carrillo, E. 2000. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 18:2231-2238.
23. Qian, P., X.M. Li, M.L. Jin, G.Q. Peng, H.C. Chen. 2004. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 22:2129-2136.
24. Mayr, G.A., V. O'Donnell, J. Chinsangaram, P.W. Mason, M.J. Grubman. 2001. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162.
25. Perreau, M., E.J. Kremer. 2005. Frequency, proliferation, and activation of human memory T cells induced by a non-human adenovirus. J Virol. 79:14595-14605.
26. Williams, E.S., I.K. Barker. 2001. Infectious Diseases of Wild Mammals (Third Edition), Iowa State University Press, Ames, Iowa, pp 119-130.
27. Giavedoni, L.D., G. Kaplan, F. Marcovecchio, M.E. Piccone, E.L. Palma. 1991. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus. J. Gen. Virol. 72:967-971.
28. Zhang, Q., Y.Q. Yang, Z.Y. Zhang, L. Li, W.Y. Yan, W.J. Jiang, A.G. Xin, C.X. Lei, Z.X. Zheng. 2002. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs. Acta Virol. 46:1-9.
29. Moraes, M.P., G.A. Mayr, P.W. Mason, M.J. Grubman. 2002. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20:1631-1639.
30. Yang, N.S., J.H. Wang, K.F. Lin, C.Y. Wang, S.A. Kim, Y.L. Yang, M.H. Jong, T.Y. Kuo, S.S. Lai, R.H. Cheng, M.T. Chan, S.M. Liang. 2005. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J. Gene. Med. 7:708-725.